Targeting of XIAP combined with systemic mesenchymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcinoma cells.

Mohr, Andrea

Targeting of XIAP combined with systemic mesenchymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcinoma cells. [electronic resource] - Stem cells (Dayton, Ohio) Nov 2010 - 2109-20 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1549-4918

10.1002/stem.533 doi


Animals
Apoptosis--physiology
Blotting, Western
Cell Differentiation
Cell Line, Tumor
Enzyme-Linked Immunosorbent Assay
Humans
Mesenchymal Stem Cells--metabolism
Mice
Mice, Nude
Pancreatic Neoplasms--therapy
TNF-Related Apoptosis-Inducing Ligand--genetics
X-Linked Inhibitor of Apoptosis Protein--genetics